Skip to main content
. 2019 Aug 21;5(1):77–84. doi: 10.1016/j.adro.2019.08.003

Table 4.

Studies on stereotactic body radiation therapy for inoperable extrahepatic cholangiocarcinoma

Study Study design No. of lesions No. of EHCC (%) No. of IHC (%) Median dose, Gy Median no. of fractions LC at 1 y OS at 1 y
Gkika et al9 Retrospective 43 26 (60%) 17 (40%) 45 NR 78% 56%
Polistina et al12 Retrospective 10 10 (100%) 0 30 3 80% NR
Barney et al16 Retrospective 10 4 (40%) 6 (60%) 55 5 100% 73%
Momm et al13 Retrospective 13 13 (100%) 0 48 12 78% NR
Mahadevan et al10 Retrospective 42 11 (26%) 31 (74%) 30 3 88% 58%
Sandler et al6 Retrospective 31 25 (81%) 6 (19%) 40 5 78% 59%
Jung et al11 Retrospective 58 25 (43%) 33 (57%) 45 3 85% 45%
Kopek et al14 Retrospective 27 26 (96%) 1 (4%) 45 3 NR NR
Tao et al5 Retrospective 69 0 69 (100%) 58 15 81% 87%
This analysis Retrospective 41 15 (37%) 26 (63%) 40 5 92% 69%

Abbreviations: EHCC = extrahepatic cholangiocarcioma; IHC = intrahepatic cholangiocarcinoma; LC = local control; OS = overall survival.